V. Kotrbová

Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.

V. Arlt, D. Phillips, C. Wolf, 2011, Toxicological sciences : an official journal of the Society of Toxicology.

The Anticancer Drug Ellipticine Is a Potent Inducer of Rat Cytochromes P450 1A1 and 1A2, Thereby Modulating Its Own Metabolism

R. Vaclavikova, L. Svobodová, J. Hudeček, 2007, Drug Metabolism and Disposition.

Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2

V. Arlt, E. Frei, M. Stiborová, 2008, Interdisciplinary Toxicology.

Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy.

J. Hudeček, Barbora Mrázová, Václav Martínek, 2011, Biochemical pharmacology.

Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.

V. Arlt, J. Mares, E. Frei, 2011, Toxicological sciences : an official journal of the Society of Toxicology.

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.

V. Arlt, D. Phillips, C. Wolf, 2008, Toxicology and applied pharmacology.

Preparation of a biologically active apo-cytochrome b5 via heterologous expression in Escherichia coli.

Václav Martínek, M. Stiborová, M. Ingr, 2009, Protein expression and purification.

Role of cytochromes P450 and peroxidases in metabolism of the anticancer drug ellipticine: additional evidence of their contribution to ellipticine activation in rat liver, lung and kidney.

Barbora Mrázová, E. Frei, M. Stiborová, 2010, Neuro endocrinology letters.

Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA.

J. Hudeček, E. Frei, M. Stiborová, 2008, Neuro endocrinology letters.